The ceramide synthase 2b gene mediates genomic sensing and regulation of sphingosine levels during zebrafish embryogenesis by Mendelson, Karen et al.
The ceramide synthase 2b gene
mediates genomic sensing and
regulation of sphingosine levels
during zebrafish embryogenesis
The Harvard community has made this
article openly available.  Please share  how
this access benefits you. Your story matters
Citation Mendelson, Karen, Suveg Pandey, Yu Hisano, Frank Carellini,
Bhaskar C Das, Timothy Hla, and Todd Evans. 2017. “The ceramide
synthase 2b gene mediates genomic sensing and regulation of
sphingosine levels during zebrafish embryogenesis.” eLife 6
(1): e21992. doi:10.7554/eLife.21992. http://dx.doi.org/10.7554/
eLife.21992.
Published Version doi:10.7554/eLife.21992
Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:34492321
Terms of Use This article was downloaded from Harvard University’s DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at http://
nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAA
*For correspondence: timothy.
hla@childrens.harvard.edu (TH);
tre2003@med.cornell.edu (TE)
Competing interests: The
authors declare that no
competing interests exist.
Funding: See page 19
Received: 30 September 2016
Accepted: 25 September 2017
Published: 28 September 2017
Reviewing editor: Didier YR
Stainier, Max Planck Institute for
Heart and Lung Research,
Germany
Copyright Mendelson et al.
This article is distributed under
the terms of the Creative
Commons Attribution License,
which permits unrestricted use
and redistribution provided that
the original author and source are
credited.
The ceramide synthase 2b gene mediates
genomic sensing and regulation of
sphingosine levels during zebrafish
embryogenesis
Karen Mendelson1,2, Suveg Pandey1, Yu Hisano3,4, Frank Carellini1,
Bhaskar C Das5, Timothy Hla3,4*, Todd Evans1*
1Department of Surgery, Weill Cornell Medical College, Cornell University, New
York, United States; 2Center for Vascular Biology, Department of Pathology and
Laboratory Medicine, Weill Cornell Medical College, Cornell University, New York,
United States; 3Vascular Biology Program, Department of Surgery, Boston
Children’s Hospital, Boston, United States; 4Harvard Medical School, Boston, United
States; 5Department of Medicine, Division of Nephrology, Icahn School of Medicine
at Mount Sinai, New York, United States
Abstract Sphingosine-1-phosphate (S1P) is generated through phosphorylation of sphingosine
by sphingosine kinases (Sphk1 and Sphk2). We show that sphk2 maternal-zygotic mutant zebrafish
embryos (sphk2MZ) display early developmental phenotypes, including a delay in epiboly, depleted
S1P levels, elevated levels of sphingosine, and resistance to sphingosine toxicity. The sphk2MZ
embryos also have strikingly increased levels of maternal transcripts encoding ceramide synthase
2b (Cers2b), and loss of Cers2b in sphk2MZ embryos phenocopies sphingosine toxicity. An
upstream region of the cers2b promoter supports enhanced expression of a reporter gene in
sphk2MZ embryos compared to wildtype embryos. Furthermore, ectopic expression of Cers2b
protein itself reduces activity of the promoter, and this repression is relieved by exogenous
sphingosine. Therefore, the sphk2MZ genome recognizes the lack of sphingosine kinase activity and
up-regulates cers2b as a salvage pathway for sphingosine turnover. Cers2b can also function as a
sphingolipid-responsive factor to mediate at least part of a feedback regulatory mechanism.
DOI: https://doi.org/10.7554/eLife.21992.001
Introduction
Sphingosine-1-phosphate (S1P) is a lysophospholipid mediator generated through sphingomyelin
metabolism, best known as a receptor-dependent regulator of lymphocyte trafficking and vascular
homeostasis. However, S1P signaling also plays key roles during embryogenesis, including develop-
mental angiogenesis, cardiogenesis, limb development and neurogenesis (Proia and Hla, 2015).
S1P binds to five G-protein-coupled receptors (S1P1–5) that are widely-expressed and function either
alone or together to regulate various developmental and physiological functions (Mendelson et al.,
2014). S1P can only be generated via phosphorylation of sphingosine by sphingosine kinase,
encoded by two genes (sphk1 and sphk2) that are highly conserved in vertebrates. In zebrafish,
sphk2 is expressed during the earliest stages of embryogenesis, including as a maternal transcript
(Mendelson et al., 2015). Mouse embryos tolerate knockout of either Sphk1 or Sphk2
(Allende et al., 2004), which implies that Sphk1 and Sphk2 function redundantly and can compen-
sate for each other’s loss. Indeed, global or hematopoietic-specific (erythrocyte and platelet) knock-
out of both Sphk1 and Sphk2 is embryonic lethal between E11.5–13.5 due to vascular
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developmental defects (Gazit et al., 2016; Mizugishi et al., 2005; Xiong et al., 2014) that are simi-
lar to those observed in mice lacking all three receptors S1P1-3 (Liu et al., 2000). Because of this
early lethality, functions for sphingosine kinases in murine embryogenesis are otherwise not well
characterized.
Zebrafish genetics has contributed much of our understanding for how S1P signaling regulates
collective cell migration during the process of primordial heart tube formation from two anterior lat-
eral mesoderm progenitor fields. A point mutation in the gene miles apart (mil), which encodes
S1P2, prevents cardiac precursor cells from migrating to the midline, resulting in formation of two
separate defective hearts or cardia bifida (Kupperman et al., 2000). The mutants two of hearts (toh)
and ko157 phenocopy the mil cardiac defect and are caused by recessive mutations in the sphingoli-
pid transporter gene, spinster2 (spns2) (Kawahara et al., 2009; Osborne et al., 2008). A model
consistent with the genetics is that spns2 functions in the yolk syncytial layer (YSL, analogous to
mammalian extra-embryonic endoderm) to transport S1P to embryonic endoderm where it activates
S1P2 signaling, coupled to Ga13 that subsequently activates RhoGEF to regulate endodermal con-
vergence (Ye and Lin, 2013). In this way, the S1P2/Ga13/Rho pathway activates cell-surface integrins
and fibronectin matrix assembly (Zhang et al., 1999) and provides endoderm with the matricellular
cues recognized by myocardial precursor cells to migrate collectively towards the midline. Receptor
signaling is mediated in part through YAP1-dependent expression of CTGF in S1P-activated endo-
derm (Fukui et al., 2014).
We (Mendelson et al., 2015) and others (Hisano et al., 2015a) generated maternal zygotic
mutants for sphk2 (sphk2MZ) and showed that these embryos phenocopy null zygotic mutants of
s1pr2 and spns2. The sphk2 transcripts can be either maternally or zygotically provided, but without
either, essential migrational cues fail to be transmitted to precardiac mesoderm and formation of
the heart tube fails. Sphk2 activity in the YSL, presumably acting in concert with the Spns2 trans-
porter, establishes a gradient of extracellular S1P essential for the provision of endodermal cues that
eLife digest Humans and other animals need a variety of fat molecules known as lipids to
survive and grow. For example, members of a large family of lipids called sphingolipids play crucial
roles in many cell processes and are essential for tissues and organs to form as animal embryos
develop. A molecule called sphingosine is the basic building block of most sphingolipids. An
enzyme known as sphingosine kinase 2 (Sphk2) converts sphingosine into a sphingolipid called
sphingosine 1-phosphate, which is released from cells and regulates communication between cells.
Another enzyme called ceramide synthase 2b (Cers2b) converts sphingosine into ceramide, which is
required for the membrane surrounding individual cells to work properly.
Excess levels of particular sphingolipids can be toxic to cells so animals carefully control the levels
of these molecules in their bodies. However, it was not clear how animal cells sense the molecules
and regulate their production and breakdown. Mendelson et al. addressed this question by studying
mutant zebrafish embryos that fail to produce Sphk2 and thus produce little or no sphingosine 1-
phosphate.
It was thought that the mutant zebrafish may experience the toxic effects of high levels of
sphingosine because they are unable to convert it to sphingosine 1-phosphate. However, the
experiments show that the mutant embryos are able to avoid this toxicity by increasing the
production of the Cers2b enzyme. Somehow the gene that encodes this enzyme is able to sense
high levels of sphingosine and responds by increasing its own production, which in turn increases
the conversion of sphingosine into the non-toxic ceramide. Further experiments found that this
mechanism for sensing and removing excess sphingosine is already operating at an earlier stage of
development when the zebrafish is just an egg.
Further work is needed to understand exactly how this sphingosine sensing mechanism works.
These findings may help us to develop new treatments for diseases caused by an imbalance in
sphingolipids, such as diabetes and cancer. This work may also help to increase the success of in
vitro fertilization (IVF) and other fertility therapies by enhancing the survival of human egg cells.
DOI: https://doi.org/10.7554/eLife.21992.002
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are recognized by overlapping sheets of migrating precardiac mesoderm. Endoderm convergence/
heart tube formation is the earliest known developmental function for receptor-dependent S1P sig-
naling. However, the studies do not rule out other receptor-independent functions for Sphk2.
We have since re-evaluated the sphk2MZ embryos and discovered phenotypes that are distinct
from those found by disruption of spns2 or s1pr2. These phenotypes appear to be caused not by
loss of S1P, but rather by the excessive accumulation of the precursor substrate sphingosine in the
absence of kinase. This led us to the discovery that embryos lacking sphingosine kinase activity toler-
ate the potentially toxic excess sphingosine because they upregulate a specific ceramide synthase
(Cers) gene, as a salvage pathway to normalize sphingosine levels. We mapped a DNA region that
mediates the transcriptional response on the cers2b promoter. It has long been noted that Cers
enzymes, in addition to encoding a Lag motif important for enzymatic activity that metabolizes
sphingosine to ceramide, also encode a homeobox domain, typically used for DNA-binding by the
HOX class of transcription factors (Levy and Futerman, 2010). Indeed, we show that Cers2b, proba-
bly by an indirect mechanism, can modulate the expression of its own promoter, and this activity
requires the HOX domain and is sensitive to sphingosine levels. Our study identifies cis-linked sphin-
golipid transcriptional response sequences, and reveals a sensing mechanism controlling sphingoli-
pid levels by a metabolic enzyme that participates in a feedback program.
Results
Maternal-zygotic mutant embryos have previously unrecognized early
developmental phenotypes
Upon close examination of developing embryos, we noticed that sphk2MZ embryos display a subtle
but consistent developmental delay during gastrulation, compared to time-matched wildtype
embryos, particularly obvious around 7–8 hr post fertilization (hpf) (Figure 1A–D). The developmen-
tal delay observed in sphk2MZ embryos was recapitulated in wildtype embryos treated with 3 mM
sphingosine (Figure 1E,F). In contrast, wildtype embryos were unaffected by culturing in the pres-
ence of ceramide (20 mM), S1P (20 mM), or N-acetyl-D-sphingosine (20 mM) (Figure 1G–I). Quantita-
tive lipidomics profiling confirmed that the mutant embryos are depleted of S1P to essentially
undetectable levels. However, this analysis also revealed that the mutant embryos have excessive
levels of sphingosine and total long chain ceramides (Figure 1J,K), likely due to substrate backup
caused by lack of sphingosine kinase and reverse reactions that form ceramide. These observations
indicate that in the absence of Sphk2, embryos accumulate excessive levels of the precursor sub-
strate sphingosine, associated with a developmental delay during gastrulation. This is however ulti-
mately tolerated by embryos, and they recover, until displaying later phenotypes in endoderm
convergence and heart formation.
Although sphk2MZ mutant embryos accumulate sphingosine and display developmental delay, we
discovered that they are relatively resistant to exogenous sphingosine-induced toxicity. Treatment of
wildtype embryos with 5 mM D-erythro-sphingosine (the active naturally occurring isomer) or 5 mM
L-erythro-sphingosine (an inactive isomer) caused developmental collapse during epiboly, a stage of
collective cell migration of epiblast cells during gastrulation. At around 50–60% epiboly, in 100% of
the treated embryos, epiboly arrests, the epiblast pinches off the yolk cell, and the yolk membrane
ruptures, leading to embryonic lethality (Figure 2A–C). Treatment with sphingosine analogues (psy-
chosine, dimethylsphingosine, and safingol) recapitulated this epiboly phenotype (Figure 2D–F).
Treatment with two chemical inhibitors of sphingosine kinases, SKI (10 mM) or BT-190 (3 mM) also
recapitulated the same embryonic lethal phenotype (Figure 2G,H). In contrast, sphk2MZ embryos
given the same treatments do not fail epiboly and (other than mild delay) develop normally
(Figure 2I) until they display later endoderm/cardiac defects. Therefore, accumulation of sphingosine
above a certain threshold is normally incompatible with embryonic development, yet tolerated in
sphk2MZ mutant embryos.
Epiboly defects caused by excess sphingosine are associated with a
disturbed cytoskeleton
The developing zebrafish blastula is comprised of three cell layers: an extra-embryonic transient epi-
thelial monolayer known as the enveloping layer (EVL), an extra-embryonic yolk syncytial layer (YSL),
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and the deep cells of the blastoderm that will eventually form the embryo proper. During early gas-
trulation, the blastoderm and the YSL move toward the vegetal pole during a process known as
epiboly. A microtubule network surrounds the yolk syncytial nuclei while another set of animal–vege-
tal-oriented microtubules emerge from the YSL into the yolk cytoplasmic layer (YCL). As epiboly pro-
gresses, two actin rings become visible; these rings serve to close the developing blastopore.
Proper cytoskeletal patterning is crucial during epiboly as chemical disruption of either the microtu-
bule or actin networks blocks epiboly progression (Solnica-Krezel, 2006).
To gain insight into why embryos treated with excessive sphingosine or with sphingosine kinase
inhibitors fail to complete epiboly, we stained treated embryos to evaluate cytoskeletal markers
associated with morphological defects. Compared to control embryos, those embryos treated with 5
Figure 1. The sphk2MZ embryos show developmental delay associated with enhanced levels of sphingosine. (A,B)
Compared to time-matched representative wildtype embryos observed at 7 or 8 hr post fertilization (hpf), the
sphk2MZ embryos (C,D) display a developmental delay during epiboly, denoted by arrows indicating the leading
edge of the blastoderm. (E, F) Wildtype embryos treated at 2 hpf with 3 mM sphingosine (sph) were similarly
developmentally delayed. Treatment of wildtype embryos with G) C8 ceramide (20 mM), (H) S1P (20 mM), or (I)
N-acetyl-D-sphingosine (20 mM) had no adverse effects on epiboly. A-I show representative embryos, n at least 25
in each of 3 independent experiments. (J) Based on lipidomic profiling at 6 hpf, the sphk2MZ embryos are
depleted of S1P (Sph-1P) and have elevated levels of sphingosine and (K) total long-chain ceramides compared to
time-matched wildtype embryos. For J and K, results are the average of three independent experiments pooling
50 embryos each; errors bars indicate the standard error of the mean.
DOI: https://doi.org/10.7554/eLife.21992.003
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mM sphingosine, 3 mM BT-190, or 10 mM SKI when stained with phalloidin show delayed progression
with aggregation of thick F-actin positive bundles within the YCL (Figure 3A–D) as well as accumula-
tion of F-actin within the cytoplasm of the EVL cells (Figure 3E–H). When control (DMSO-treated)
embryos were at 50% epiboly, the treated embryos ranged typically from 25–40% epiboly. These
thick actin bundles may cause abnormal contractile forces that disrupt the YCL; alternatively, these
forces may create resistance to vegetal pulling of the EVL.
Figure 2. Excess sphingosine results in gastrulation defects and embryonic lethality, which is abrogated in the
context of a sphk2MZ mutation. (A) Embryos cultured in DMSO display normal coverage of the yolk by the
developing blastoderm during epiboly at 7 hpf. (B) Treatment of wildtype embryos with 5 mM D-erythro-
sphingosine (the active naturally occurring isomer) or (C) 5 mM L-erythro-sphingosine (the inactive isomer) caused
stalling of embryonic development during epiboly, rupture of the yolk membrane, and failure of the embryos to
complete gastrulation. This phenotype was recapitulated by embryos treated with (D) 5 mM D-galactosyl-ß1–1’-D-
erythro-sphingosine (Psychosine), (E) 10 mM dimethylsphingosine (DMS), and (F) 20 mM L-threo-
Dihydrosphingosine (Safingol). Treatment of wildtype embryos with two chemical inhibitors of sphingosine kinases,
(G) SKI (10 mM) or (H) BT-190 (3 mM) recapitulated the catastrophic embryonic phenotype. (I) The majority (144/173,
83%) of wildtype (WT) embryos treated with 5 mM sphingosine exhibited a lethal phenotype during gastrulation,
whereas the majority (175/176, 99%) of the sphk2MZ embryos treated with 5 mM sphingosine completed
gastrulaton and early development, only subsequently displaying the cardiac bifid phenotype observed in sphk2MZ
embryos, with no additional defects. Control embryos were cultured in DMSO vehicle (1%). Shown are
representative embryos, n is indicated, from at least three independent experiments.
DOI: https://doi.org/10.7554/eLife.21992.004
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Staining with an antibody against a-tubulin revealed a thickened microtubule layer within the YSL
as well as microtubule aggregation in certain areas of the YCL and other areas that are completely
devoid of microtubules (Figure 3I–N). Note that the progression of the EVL appears to be more
delayed compared to the deep cell layer (indicated by brackets in panels I-K). E-cadherin staining
Figure 3. Excess sphingosine disrupts actin and microtubule organization and reduces junctional E-cadherin. (A)
During gastrulation, actin accumulates at the vegetal pole as shown by phalloidin staining in DMSO-treated
control embryos at ~50% epiboly (5.3 hpf). Phalloidin staining shows aggregation of thick F-actin positive bundles
within the yolk cytoplasmic layer (YCL) of embryos treated with (B) 5 mM sphingosine, (C) 3 mM BT-190, or (D) 10
mM SKI (indicated by asterisks). For A-D, the average percent progression of the EVL is indicated as measured
from the pole for a representative set of 5 embryos for each condition. (E–H) Shown at higher magnification,
F-actin also accumulates within the cytoplasm of the enveloping cells in the treated embryos compared to DMSO-
treated controls. During epiboly, two perpendicular microtubule layers are visible in DMSO-treated embryos at the
YSL (I) and in the YCL (L). Staining with a-tubulin revealed a massively thickened microtubule layer within the YSL
(as indicated by brackets, which also highlights the delayed progression of the EVL compared to deep layer cells)
in embryos treated with (J) 5 mM sphingosine or (K) 3 mM BT-190 as well as (M,N) microtubule aggregation in
certain areas of the YCL (denoted by asterisks) and other areas that are completely devoid of microtubules.
Indicated by brackets in (I-K), the progression of the EVL appears to be more delayed compared to the deep cell
layer. (O) DMSO-treated embryos display junctional E-cadherin staining of the EVL cells. (P,Q) Reduced junctional
E-cadherin staining of the EVL cells and accumulation of staining within the EVL cytoplasm in embryos treated with
5 mM sphingosine or 3 mM BT-190. For all panels, representative embryos are shown, n is at least 100 from at least
three independent experiments.
DOI: https://doi.org/10.7554/eLife.21992.005
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shows reduced localization at EVL cell membrane junctions and accumulation of staining within the
EVL cytoplasm in embryos treated with 5 mM sphingosine or 3 mM BT-190, compared to DMSO-
treated control embryos (Figure 3O–Q).
Cers2b transcripts are enhanced in sphk2MZ embryos
The sphk2MZ embryos display elevated sphingosine and ceramide levels, yet are relatively resistant
to gastrulation defects caused by excess sphingosine, suggesting that they employ a sphingosine
kinase-independent mechanism to handle substrate accumulation. We hypothesized that sphk2MZ
embryos might regulate one or more genes encoding enzymes responsible for the biosynthesis of
sphingosine from ceramide (ceramidases) or conversion of sphingosine into ceramide (ceramide syn-
thase). Therefore we examined expression levels for all the ceramide synthase and ceramidase genes
that are annotated in the zebrafish genome (some of which are duplicated). This analysis showed
only one gene, cers2b, that is significantly and strikingly upregulated in sphk2MZ embryos compared
to wildtype embryos (Figure 4A). This suggests that sphk2MZ embryos up-regulate a salvage path-
way for sphingosine turnover through a specific ceramide synthase gene, cers2b, which could poten-
tially protect these embryos from sphingosine-mediated gastrulation defects.
Thus, we hypothesized that knockdown of Cers2b in sphk2MZ embryos should recapitulate the
gastrulation phenotype observed following treatment of wildtype embryos with sphingosine. Knock-
down experiments were performed using a translation blocking morpholino (MO) against cers2b.
Because MOs can have off-target or toxicity effects, the MO was titrated to define reagent amounts,
e.g. 5 ng, having no effect following injection into wildtype embryos. Injection of the same amount
of cers2b MO into sphk2MZ embryos resulted in a phenocopy of the sphingosine-induced toxicity
defect during early gastrulation in 60/288 (21%) embryos from four independent experiments, with
failure of epiboly and pinching of the blastoderm from the yolk cell (Figure 4B,C, p=0.015). This sug-
gests that transcriptional up-regulation of cers2b is important for sphk2MZ embryos to resist the
buildup of excessive sphingosine and complete epiboly.
It is perhaps not surprising that the morphant phenotype is not fully penetrant since morphant
knockdowns may be partial or transient. They may also be subject to off-targeting. Therefore, to
more rigorously test whether Cers2b compensates for loss of Sphk2 to relieve excess sphingosine,
we designed sgRNAs to target mutation of cers2b. We established a line of fish carrying a 23 bp
deletion in exon6 of the cers2b gene that is predicted to delete most of the Lag domain and gener-
ate a frame-shift with a premature stop codon and a truncated protein that would lack enzymatic
function. This mutant allele was tolerated for development and was crossed onto the background of
the sphk2 mutant, to raise sphk2MZ; cers2b+/- adult fish. When crossed to each other, the resulting
clutches consistently had approximately 25% of the embryos that phenocopied the gastrulation
defect caused by treating wildtype embryos with excess sphingosine (Figure 4D). These embryos
rapidly perish, which precluded our ability to measure directly the ceramide levels or genotype the
dying embryos. However, the genetic interaction of sphk2 and cers2b is fully consistent with sphin-
gosine-associated up-regulation and compensation from Cers2b. We note that the cers2b gene fails
to be up-regulated in the sphk2 morphants (Figure 4E), and neither do these embryos show
increased ceramide levels (Figure 4F). Likewise, wildtype embryos treated with sphingosine fail to
activate expression of cers2b (Figure 4G) or to significantly increase levels of total ceramides
(Figure 4H). We crossed sphk2+/- females with either wildtype males or mutant null males, to com-
pare the relative levels of cers2b transcripts or sphingosine. In the former case, the embryos are 50%
heterozygous and 50% wildtype (none are null), while in the latter case 50% of the embryos are
zygotic null (and the other 50% are heterozygous). If the sphk2 zygotic null mutants were similar to
sphk2MZ mutants, we would expect to measure half the levels of increased sphingosine in this latter
cohort compared to what is measured in the sphk2MZ mutants. However, we found the levels were
not increased compared to the control cohort and neither were overall S1P levels depleted
(Figure 4I). Therefore, the data suggest that the increased sphingosine level associated with tran-
scriptional activation of cers2b is dependent on the maternal loss of Sphk2 function, and neither
wildtype embryos nor morphants are able to respond to increased sphingosine levels by up-regula-
tion of the cers2b gene.
Mendelson et al. eLife 2017;6:e21992. DOI: https://doi.org/10.7554/eLife.21992 7 of 21
Research article Biochemistry Developmental Biology and Stem Cells
Enhanced cers2b promoter activity in Sphk2MZ embryos compared to
wildtype embryos
The strikingly higher cers2b transcript levels in sphk2MZ embryos suggest that this gene may have
cis-regulatory elements that respond to sphingosine levels (sphingosine response elements). If true,
these elements might confer promoter activity to a reporter gene, which like the endogenous gene
should be more active in sphk2MZ embryos compared to wildtype embryos. The cers2b gene is
located on chromosome 16, with a transcriptional start site approximately 1.7 kb downstream of the
Figure 4. The sphk2MZ embryos express strikingly high levels of cers2b transcripts. (A) Analysis of ceramide
synthase and ceramidase genes by qRT-PCR shows that cers2b is significantly upregulated in sphk2MZ embryos
(p=0.019) compared to wildtype embryos at 2 hpf. (B) Representative wildtype or (C) sphk2MZ embryos following
injection with 5.3 ng of a cers2b translation blocking morpholino (MO), alongside (D) embryos derived from a
sphk2MZ; cers2b+/- incross. For wildtype embryos, 155/161 (96%) completed normal gastrulation, epiboly, and
appeared normal at 2 dpf. Following injection into sphk2MZ embryos, 60/288 or 21% from 4 separate experiments
recapitulated the early gastrulation lethality phenotype (p=0.0154). Correspondingly, 43/190 or 23% of embryos
derived from crossing sphk2MZ; cers2b+/- adult fish recapitulated early gastrulation lethality phenotype by 9 hpf. (E)
Sphk2 morphant embryos fail to upregulate cers2b transcripts and (F) did not vary in ceramide levels when
compared to those injected with control morpholino. (G) Embryos exposed to 5 uM sphingosine in culture
similarly fail to upregulate cers2b transcript levels and (H) showed no differences in ceramide accumulation. (I)
There were no significant differences in sphingosine (Sph) or S1P (Sph-1P) levels in embryos with maternally
deposited Sphk2, consistent with normal development. Embryos were harvested for both qPCR and lipid
measurements at 6 hpf. All experiments were repeated at least three times with equivalent results.
DOI: https://doi.org/10.7554/eLife.21992.006
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3’ end of the adjacent celf3b gene. The putative promoter region of cers2b, including the entire
1680 bp non-coding region directly upstream of exon1 was isolated by PCR and cloned upstream of
a firefly luciferase reporter gene. This construct was co-injected with RNA encoding a control renilla
luciferase enzyme into fertilized eggs of wildtype or sphk2MZ embryos. In three independent experi-
ments using a total of 114 embryos of each genotype per experiment (n = 38 samples, each sample
comprised from three embryos) the ratio between firefly luciferase to renilla luciferase (FL/RL) was 9-
fold higher in sphk2MZ embryos compared to wildtype embryos (Figure 5A, p<0.0001). We note
that this difference was entirely attributable to the luciferase reporter, as the control RL levels were
highly consistent in all experiments. To localize the sequences of the cers2b promoter that mediate
this response, shorter promoter fragments were cloned into the reporter, progressively deleting 5’-
upstream sequences, and compared for activity in wildtype and mutant embryos. The results of this
study are also shown in Figure 5A. Deletion of the first 49 bp (1631 bp construct) decreased the
enhanced responsiveness to 6-fold, while deletion of 83 bp (1597 bp construct) reduced it to a 2-
fold difference. Deletion of the upsteam 400 bp (1281 bp construct) essentially eliminated promoter
activity in both wildtype and mutant embryos. These results indicate that key regulatory regions con-
ferring both promoter activity and enhanced response in sphk2MZ mutant embryos are present in
the 400 bp region at the 5’ end of the 1.7 kb promoter construct. Indeed, when this 400 bp frag-
ment was cloned upstream of an independent minimal SV40 promoter, although the basal activity
was somewhat lower, the resulting construct fully recapitulates a 9-fold enhanced activity in sphk2MZ
embryos compared to wildtype (Figures 5A and 400 bp).
The ability of mutant embryos to enhance expression of cers2b in sphk2MZ embryos indicates a
sensing mechanism to engage this alternative metabolic pathway and resist toxicity caused by
excess sphingosine. An attractive candidate component of this sensing mechanism would be Cers2b
itself, since it is the ideal protein for recognizing sphingosine and thereby might be differentially
impacted depending on sphingosine levels. We were struck by the additional observation that many
vertebrate ceramide synthase enzymes, including Cers2b, encode not only metabolic activity
domains, but also a homeobox domain, typically found in homeobox class transcription factors. This
raises the possibility that Cers2b, in addition to functioning to sense sphingosine levels, could poten-
tially impact the transcriptional activity of its own or other genes.
To test if Cers2b can impact expression of its own promoter, the luciferase reporter under control
of cers2b upstream sequences was co-transfected into HEK293T cells with an expression vector for
Cers2b or a control empty expression vector, along with a control renilla luciferase expression vector
to normalize for transfection efficiency and lysate preparation. Expression of Cers2b consistently and
significantly decreased expression of the cers2b:luciferase reporter (Figure 5B), indicating that
Cer2b can be a functional repressor of its own gene. Addition of 10 mM sphingosine to the trans-
fected cells relieved this repressor activity so that the reporter was expressed at levels not signifi-
cantly different from the control conditions without Cers2b. To test if this activity was dependent on
the homeobox domain, a two amino acid mutation was introduced into the Cers2b coding sequence
(R121W, R122S), which is predicted to impair the conserved structure of the homeodomain (Bane-
rjee-Basu and Baxevanis, 2001). Like addition of sphingosine, the RR121-122WS alteration elimi-
nated the capacity for Cers2b to repress its own promoter (Figure 5B).
We also generated by site-directed mutagenesis an isoform for Cers2b that is mutant in the Lag
domain (HH212-213DD). This isoform is predicted to be enzymatically dead, and so we compared
the effect of this protein to the wildtype protein and the isoform with a mutant HOX domain for
Cers2 promoter regulation. As shown Figure 5B, The Lag-mutant protein retains the ability to
repress the reporter controlled by the cers2b promoter. Compared to the wildtype protein, the Lag-
mutant fails to generate ceramide above background levels (Figure 5C). In contrast, the HOX
mutant protein retains the ability, equivalent to the wildtype protein, to increase ceramide levels,
but is unable to repress activity of the promoter. Therefore, the HOX domain is required for cers2
gene regulation, independent of enzymatic function.
Cers2b association with the nuclear membrane is enhanced by
sphingosine exposure
Since forced expression of Cers2b can repress its own promoter, dependent on the HOX domain,
we considered the possibility that Cers2b might be able to function directly as a transcription factor.
In this case, it would be expected that some fraction of the protein is localized in the nucleus to
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Figure 5. The cers2b promoter is relatively active in Sphk2MZ embryos compared to wildtype embryos, and is
repressed by Cers2b, dependent on the HOX domain. (A) Shown are relative luciferase activities from three
independent experiments comparing the ratio between expression of firefly luciferase (FL) regulated by the cers2b
promoter to renilla luciferase (RL), derived from co-injection of renilla luciferase RNA. The ratio (FL/RL on the Y
axis) is significantly enhanced in sphk2MZ embryos compared to wildtype embryos, p<0.0001. To demonstrate that
this reflects cis-regions of the cers2b promoter, shorter promoter fragments containing progressively less
upstream sequences were similarly compared. Much of the promoter activity was found to reside in the upstream
400 bp, and transfer of this sequence to a heterologous (minimal SV40) promoter was sufficient to transfer the
response in sphk2MZ embryos. (B) Similar luciferase reporter assays were carried out in HEK293T mammalian cells.
Ectopic expression of Cers2b caused a significant repression of the cers2b promoter-regulated reporter compared
to empty expression vector control. This repression was relieved in cells treated with 10 mM sphingosine, which
does not affect basal level of the reporter (empty vector +sphingosine). Repression was also abrogated by
mutations predicted to disrupt function of the homeobox (HOX) domain, while a mutation in the catalytic (LAG)
domain did not impact the capacity of the protein for repression. (C) When Cers2b is overexpressed in HEK293T
cells, the ceramide levels increase due to its catalytic activity, which is unaffected by the homeobox (HOX)
mutation but disrupted entirely by the catalytic (LAG) domain mutation. This indicates the repressive activity on
the promoter is independent of the catalytic activity of Cers2. All results are averaged from three independent
experiments; bars indicate standard error of the mean. Statistical significance is derived by one-way ANOVA and
indicated by * (p<0.05), ** (p<0.01), *** (p<0.001). N.S. denotes not significant.
DOI: https://doi.org/10.7554/eLife.21992.007
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interact with its own promoter or other genes. We used confocal microscopy of HEK293T cells trans-
fected with a vector to express a Cers2-GFP fusion protein, in order to visualize localization in live
cells (Figure 6A). As expected, Cers2-GFP protein is localized primarily to the ER, throughout the
cell including contiguous to the nuclear membrane. Following exposure to 10 mM sphingosine, a
condition that leads to de-repression of the reporter that is regulated by the cers2b promoter, there
is a considerable change in the distribution of the fusion protein and notably enhanced signal associ-
ated with the nuclear membrane. There did not appear to be significant levels of the fusion protein
in the nucleus either at steady state or following sphingosine exposure. We also compared expres-
sion levels of the protein by western blotting, following separation of nuclear and cytosolic extracts.
In this case there was a marked enrichment for Cers2b in the nuclear fraction following exposure to
sphingosine (Figure 6B). However, when the nuclear fraction was further separated, we found that
sphingosine induction caused Cers2b association primarily with nuclear membranes (Figure 6C),
consistent with the confocal imaging. Therefore, we did not find evidence that Cers2 functions as a
nuclear protein and while function as a transcription factor can’t be ruled out, it appears more likely
that Cers2b impacts promoter activity by an indirect mechanism, perhaps acting at the nuclear mem-
brane to process nuclear sphingosine.
Figure 6. The subcellular localization of Cers2 protein is altered by increased sphingosine levels. HEK293T cells transfected with a Cers2-GFP
expression plasmid were examined after 6 hr exposure to 10 uM sphingosine in culture. (A) Cells treated with sphingosine (Sph) show subcellular
relocalization of Cers2b-GFP (green) with more overlap within nuclear regions (DAPI, blue) as seen in the z-stack (side panels). (B–C) Western blotting
analysis of lysates probed with antibodies specific to Cers2, GAPDH (as a control for cytoplasmic proteins), TBP (as a control for nuclear proteins) or
LaminB1 (as a control for nuclear membrane associated proteins). (B) Subcellular fractionation into cytoplasmic (Cyto) and nuclear (Nuc) lysates confirms
increased nuclear association of Cers2 in cells treated with sphingosine. (C) Fractionation using a nuclear membrane isolation kit indicates Cers2 is most
enriched in the nuclear membrane fraction.
DOI: https://doi.org/10.7554/eLife.21992.008
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The cers2b gene is activated during oogenesis in the absence of Sphk2,
associated with increased sphingosine levels
Given the early activation of Cers2b in the sphk2MZ embryos, we hypothesized that this could repre-
sent a protective mechanism to remove excess sphingosine during oogenesis. In this case, we would
expect that sphingosine levels would be relatively high and the cers2b gene already activated even
in mutant oocytes. Lipidomics comparing wildtype and sphk2 mutant oocytes confirmed, similar to
the sphk2MZ embryos, a lack of S1P and relatively higher levels of sphingosine in the mutant oocytes
(Figure 7A), although in this case the total ceramide levels were not significantly different
(Figure 7B). We also carried out in situ hybridization experiments probing oocytes derived from ova-
ries of sphk2 mutant females. This confirmed strikingly higher levels of cers2b transcripts in the
Figure 7. Transcriptional changes during oogenesis underlie sphk2MZ resistance to sphingosine buildup. Oocytes
isolated from wildtype and sphk2-/- female fish show (A) increased sphingosine (Sph) levels in mutant oocytes
associated with loss of S1P (Sph-1P) with (B) no difference in total ceramide levels. (C) Oocytes derived from
sphk2-/- oocytes showed significant upregulation of cers2b transcripts, as imaged following in situ hybridization.
Note that signal in the wildtype oocytes was equivalent to background staining using a sense-strand control
probe. (D) Correspondingly, embryos derived from sphk2-/- females (right) showed relative tolerance to
sphingosine accumulation when compared to those from wildtype females (left) when cultured in medium with 5
uM sphingosine. For (A, B) . results are averaged from three independent experiments using at least 50 embryos
per measurement. For (C,D), representative embryos are shown, n > 25, from at least three independent
experiments.
DOI: https://doi.org/10.7554/eLife.21992.009
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mutant oocytes compared to wildtype (Figure 7C). Furthermore, early embryos derived from a
sphk2 null female are resistant to rupture when exposed to exogenous sphingosine, despite a func-
tional sphk2 allele inherited from the wildtype male (Figure 7D). All the data are fully consistent with
a sphingosine-induced Cers2b-based protective mechanism during oogenesis.
Discussion
S1P signaling has great capacity to impact embryonic development through complex receptor-
dependent G-protein coupled pathways that cross-talk with each other and additional developmen-
tal signaling programs. It is less appreciated that regulation of sphingolipid metabolism may have
additional receptor-independent functions equally critical for early developmental decisions such as
cell proliferation, survival, and tissue morphogenesis. Previous studies confirmed that Sphk2 is an
enzyme required to generate S1P used during early embryogenesis in an S1P receptor-dependent
manner to regulate endoderm convergence and heart tube formation (Hisano et al., 2015a;
Mendelson et al., 2015). Here we confirmed that sphk2MZ mutant embryos are depleted of S1P,
but we also found additional previously unrecognized phenotypes that result from dysregulation of
sphingolipid metabolism. Importantly, the mechanistic underpinnings of this phenotype revealed a
previously unknown regulatory mechanism by which sphingolipid metabolism is achieved at the level
of ceramide production.
The sphk2MZ mutant embryos have increased sphingosine levels due to the failure to convert this
substrate to S1P. These embryos are developmentally delayed during gastrulation, although they
eventually recover and can complete epiboly. This delay can be phenocopied in wildtype embryos
by culturing in the presence of excess sphingosine, suggesting that the two observations are linked.
Even with the increased sphingosine levels, the mutant embryos are nevertheless relatively resistant
to toxicity caused by excess sphingosine. This indicates that they have engaged an alternative pro-
gram to convert sphingosine to a non-toxic metabolite. The mutant embryos express strikingly high
levels of cers2b transcripts, strong evidence for this anticipated salvage pathway for sphingosine
turnover. Knockdown and genetic interaction experiments suggest that transcriptional up-regulation
of cers2b is important for mutant embryos to complete epiboly. Finally, cers2b promoter activity can
be transferred to an independent reporter gene, functioning in cis to promote higher expression lev-
els in sphk2MZ embryos compared to wildtype embryos. Upstream sequences confer sphingosine
responsivity, located within a 400 bp region. Cers2b protein itself can partially repress activity of this
promoter, dependent on a HOX domain but independent of enzymatic activity, and this repression
is relieved by addition of sphingosine. These findings reveal a previously unrecognized mechanism
by which the genome senses and modulates sphingosine levels during embryogenesis.
The reason that Sphk2MZ embryos are delayed in epiboly is not known, but we speculate that it is
caused by destabilization of the actin-microtubule cytoskeletal network due to accumulation of
excess sphingosine. A similar delay is recapitulated in wildtype embryos treated with 3 mM sphingo-
sine, while increasing this to 5 mM causes rupture of the epiblast associated with massive disorgani-
zation of actin and microtubule networks that are essential for ‘pulling’ the blastoderm around the
yolk cell. Upregulation of cers2b in the mutant embryos manages to maintain sphingosine levels
below this ‘catastrophic’ threshold, generating a phenotype similar to wildtype embryos treated
with the 3 mM lower dose. A good candidate for mediating the connection to cytoskeleton is the
p21-activated kinase Pak1. Pak kinases can localize to cortical actin structures, and expression of
activated mutants induces cytoskeletal reorganization, including loss of actin stress fibers
(Manser et al., 1997). Pak1 signaling is also implicated during epiboly in sustaining E-cadherin at
adherens junctions (Tay et al., 2010), which also fails in the sphingosine-treated embryos. Interest-
ingly, sphingosine was shown previously to activate PAK1 in mammalian cells in a concentration-
dependent manner (Bokoch et al., 1998). The dramatic blastoderm constriction phenotype is
remarkably similar to the maternal-zygotic betty boop (bbp) mutant embryo (Holloway et al.,
2009), suggesting that it could also involve defects in a p38/MAPKAPK2 pathway. Although S1P2
couples through Ga13 to control cell migration (Ye and Lin, 2013), and Ga13 signaling plays an
important role in epiboly progression (Solnica-Krezel, 2006), the receptor-dependent pathway
seems less likely to be involved, since similar phenotypes are not observed in embryos lacking S1P
receptors (Hisano et al., 2015b).
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On the other hand, it has long been recognized that while Sphk1 is localized primarily in the cyto-
plasm, Sphk2 is mostly a nuclear protein, and may be particularly important for regulating nuclear
sphingosine levels, which could impact DNA synthesis (Igarashi et al., 2003) or oxidative stress oth-
erwise leading to DNA damage and apoptosis (Van Brocklyn and Williams, 2012). We note that
sphk2 is expressed as a maternal transcript, and this is also true of cers2b in the sphk2MZ mutant
embryos. This suggests that the genome might be especially vigilant at limiting nuclear sphingosine
levels during oogenesis in order to protect genomic integrity. In this context, it is of interest to note
previous studies where sphingolipids, particularly S1P, were shown to protect oocytes from apopto-
sis induced by genotoxic stress or chemotherapy in mice and primates (Morita et al., 2000). S1P
treatment in vitro was shown to induce oocyte survival (Hannoun et al., 2010), and acid ceramidase
is known to modulate oocyte apoptosis (Eliyahu et al., 2010). Thus, our findings could have practical
implications in reproductive sciences and in vitro fertilization technology.
It is interesting that Cers2b contains a homeobox domain, required for repressing transcriptional
activity of its own promoter. This leads to a model whereby under conditions with limiting sphingo-
sine levels the Cers2b enzyme functions to repress its own gene and thereby limit sphingosine con-
version to ceramide (perhaps also favoring conversion to S1P). If sphingosine levels exceed a certain
threshold, for example by loss of Sphk2 activity and/or increased ceramidase activity, this is recog-
nized by binding of sphingosine to the Lag domain of Cers2b, which relieves Cers2b repression
activity, perhaps through a conformational alteration, and activates enzymatic activity to remove
sphingosine by metabolism to ceramide. Currently we can’t rule out post-transcriptional regulation
of the cers2b gene in response to increased sphingosine levels. However, we note that the cers2b
transcript levels are markedly enhanced, at levels that are recapitulated by the promoter using a
luciferase reporter with no shared RNA sequences. Furthermore, the increase is highly specific to the
cers2b transcript.
15 years ago Venkataraman and Futerman speculated whether the presence of a homeobox
domain suggests that the enzymes might act as dual sphingosine sensors and transcriptional regula-
tors, analogous to how sterol regulatory element binding protein (SREBP) senses and modulates
sterols (Venkataraman and Futerman, 2002). Consistent with our results, overexpressing mamma-
lian Cers2 in HT29 colon cancer cells caused a modest but significant reduction in transcription of a
reporter gene regulated by an acid ceramidase promoter (Tirodkar et al., 2015), suggesting that
Cers2 might have additional pathway-relevant targets. The single Drosophila Cers ortholog, Schlank,
also has a homeodomain, in addition to the Lag motif. Interestingly, schlank mutants could be res-
cued by expression of variant proteins lacking a functional Lag motif, as long as they contained the
homeodomain and a nuclear localization signal (Voelzmann et al., 2016). While the mechanism for
Cers2b action during zebrafish embryogenesis remains unclear, our results suggest the critical role
played by this ER/nuclear membrane-localized enzyme is in autoregulation of sphingolipid
metabolism.
Our data provide new evidence for a role of ceramide synthase in vertebrate embryonic develop-
ment, but the concept of a dual role in metabolism and transcription has been considered previ-
ously. In fact, together with our observations, it seems likely that Cers2b may play a central role in
coordinating a response following sensing of sphingosine levels to the transcriptional machinery in
the regulation of sphingolipid metabolism.
Our observation linking Cers2b to genomic sensing/transcription was only made possible by close
examination of subtle phenotypes in the sphk2MZ mutant embryo. The identical phenotype caused
by excess sphingosine in wildtype embryos (pinching off of the blastoderm during epiboly and
embryonic lethality) was also seen in sphk2 morphants. This suggests that mutants (but not mor-
phants or wildtype embryos treated with sphingosine) are able to recognize the defect and have
time to take corrective action through engaging the salvage Cers2 pathway. The process apparently
occurs during oogenesis, since it involves the expression of maternal transcripts. The capacity of
zebrafish embryos to compensate for mutant genes may be relatively robust (see also [Rossi et al.,
2015]), and at least partially responsible for the reported disparity between mutant and morphant
phenotypes (Kok et al., 2015). It can also be fortuitous for revealing novel biological regulatory
mechanisms.
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Materials and methods
Maintenance of zebrafish
Wildtype (AB/TU hybrid) and mutant zebrafish were maintained at 28.5C and staged as described
(Kimmel et al., 1995). Sphk2MZ were generated (sphk2wcm2) and characterized as described previ-
ously (Mendelson et al., 2015). To generate a cers2b mutant line, a sgRNA was designed using
CHOPCHOP (https://chopchop.rc.fas.harvard.edu) to target the 20 bp sequence AGTACCAGTAC
TGAGACGGC in exon6 within the Lag domain of the cers2b gene. The sgRNA was synthesized
using 125 ng gblock (IDT) and transcribed in vitro using the MegaShortScript T7 kit
(ThermoFisher, Waltham, MA). 150 pg RNA was injected into fertilized eggs with 250 pg recombi-
nant Cas9 protein (Pnabio) in a volume of 2 nl per injection. F0 founder fish transmitting mutant
alleles were identified using T7 exonuclease assays and F1 embryos raised to adulthood. One line
was established (cers2bwcm18) that transmits a 23 bp deletion allele, with loss of the nucleotide
sequence GTCTCAGTACTGGTACTACATGC, causing a frameshift that deletes Cers2b starting at
amino acid S178, generating a mutant protein encoding subsequently:
YDLEEMWKGFPTLTLLPAGTGLLHLSPVQCGVGRQAQGL*.
Quantitative RT-PCR
Staged embryos were homogenized with TRIzol (Ambion) and total RNA was isolated (Qiagen).
Total RNA (1 mg) was used to generate cDNA using reverse transcriptase and random hexamers
(Roche). LightCycler 480 SYBR Green 1 Master Mix (Roche) was used to analyze cDNA by quantita-
tive RT-PCR using the Light Cycler 480II (Roche). The PCR cycle conditions were 95C for 15 min fol-
lowed by 40 cycles at 94C for 14 s, 54˚C for 30 s, and 72˚C for 30 s. Ct values were calculated using
the DDCt method (Livak and Schmittgen, 2001), based on the median value from a triplicate set.
Each value was normalized to levels of 18S transcripts. Statistical significance was determined using
a two-tailed Student’s t-test. Primer sequences were designed using Primer3 and were:
cers1 FOR: 5’-ACATGGACGAATGGAGGAAG
REV: 5’-CGAGAATGCCTATGTTGTGG
cers2a FOR: 5’-AACCAAGAGCGACCAAACC
REV: 5’-CCAGCAATGAAAGCAACAAG
cers2b FOR: 5’-CGCAGAAATCAAGACAGACC
REV: 5’-AGCAAGACCACCGATGAAG
cers3a FOR: 5’-TCAGGAGGAGACGAAACCAG
REV: 5’-CCTCCAATGAATGCCAACAG
cers3b FOR: 5’-TGTAAAAAGCTGGGCTGGTC
REV: 5’-CTCCTCCAAAAGTCGAGCAC
cers4a FOR: 5’-CAAACTGGAGGCGTTCTACC
REV: 5’-AGCCATGACTGAATCTGACG
cers4b FOR: 5’-GAAACCGCAGAAATCTGGAC
REV: 5’-ACCAGGTAGAAGGCAAACCTC
cers5 FOR: 5’-ACAAACCCAGCACAAGAACC
REV: 5’-CAGAAAACGCATCCCATACG
cers6 FOR: 5’-AATCCAACGCTGGTTCAGAC
REV: 5’-TTCTTCAGGAAGCGCACAC
asah1a FOR: 5’-TATGTTGGCATGCTCACTGG
REV: 5’-CCCATCAAAGTCAAAGCGTTC
asah1b: FOR: 5’-CATGATTCAGGCCATCAGAG
REV: 5’-GGCAGAGTGTCCACCATTAAC
asah2: FOR: 5’-TAAGAGAGTCGTGTTCGTCACC
REV: 5’-TCCTGAATGTGTGTGTGTGC
acer1 FOR: 5’-CAAACACTTCCCTTCCTTCG
REV: 5’AGGCATTGGCTGTAGGTTTG
acer2 FOR: 5’-GTGGTTTCCCAAGAGATACCTG
REV: 5’-TGGAGTTTATCGCTGGCTTG
acer3 FOR: 5’-ATCTACAGCTGCTGCGTCTTTG
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REV: 5’-AATAGTTAACGGCACGCTCTTG
Chemical treatment of zebrafish embryos
Wildtype and sphk2MZ zebrafish embryos were obtained at the one cell stage from paired adults,
cultured in system water until 2 hpf and then grouped into individual 60 mm petri dishes, each con-
taining 35 embryos in 10 mL of 1x E3 buffer, 1% DMSO, and 1 mM Tris pH 7.5. Compounds were
diluted in DMSO to 10 mM stocks, and added to the cultured embryos to a final concentration of: 5
mM D-erythro-sphingosine C18 chain (Avanti), 5 mM L-erythro-sphingosine C18 chain (Matreya), 5
mM D-galactosyl-ß1–1’-D-erythro-sphingosine (Psychosine) (Avanti), 10 mM dimethylsphingosine
(DMS) (Tocris), 20 mM L-threo-Dihydrosphingosine (Safingol) (Avanti), 20 mM C8 ceramide (Enzo Life
Sciences), 20 mM spingosine-1-phosphate (d18:1) (S1P) (Avanti), 20 mM N-acetyl-D-sphingosine
(Sigma), 10 mM sphingosine kinase inhibitor 2 (SKI, Cayman Chemicals), or 3 mM BT-190. BT-190
compound is identical to RB-046 and was synthesized as described (Baek et al., 2013). For these
experiments the shorter chain ceramides were used because they can be dissolved and accurately
measured. In contrast, long-chain ceramides are extraordinarily difficult to manipulate in vitro due to
hydrophobicity making it difficult to accurately define the exposure level of phospholipid. The mor-
phology of developing embryos was scored at 6 hpf.
Morpholino oligomer injection
A translation blocking morpholino oligomer (MO) was designed to target the 5’ UTR around the
start codon of Cers2b to block mRNA translation (5’-CTCGCTCAGACCCGCCAGCATTTCA) and was
purchased from Gene Tools (Philomath, OR). Blast analysis indicated the MO is specific for cers2b
(no overlap with other sequences). All morphants were compared to stage matched embryos that
were injected with the same concentrations of a standard control morpholino (Gene Tools). Each
MO was titrated by injection into 1–4 cell fertilized embryos to determine a minimal dose for the
reproducible phenotype. Neither the control or cers2b-specific MO disrupted normal development
of wildtype embryos. Microinjection of MOs was performed using a PLI-100 Pico-Injector (Harvard
Apparatus).
Preparation of tissue samples for lipid analysis
Fifty zebrafish embryos were dechorionated using protease for 5 min and washed using E3 solution.
The pellets were centrifuged for 2 min and the supernatants removed. The samples were submitted
to the analytical core facilities at Stonybrook University or the Medical University of South Carolina
for ceramide and sphingolipid analysis. Sphingolipids were extracted after the addition of internal
standards and quantified by LC/MS/MS as described previously (Mendelson et al., 2013).
Immunofluorescence for F-actin staining
Embryos were fixed overnight in 4% paraformaldehyde in PBS at 4C. Following two washes for 5
min each in PBSTw (PBS + 0.1% Tween-20), embryos were manually dechorionated. To permeabilize,
embryos were incubated for 2 hr in PBS + 2% Triton X100. Following two washes for 5 min each in
PBSTw, embryos were blocked for 1 hr with 2% BSA in PBSTw. Embryos were incubated for 2 hr at
RT in Alexa 546 phalloidin (Invitrogen) diluted 1:40 in 2%BSA/PBSTw. Following 6 washes for 10 min
each in PBSTw, embryos were mounted in agarose for confocal microscopy.
Immunofluorescence for microtubule staining
Following fixation in microtubule stabilizing buffer [MSB] at RT for 2 hr, embryos were rinsed briefly
in PBSTw and dechorionated. MSB composition is 80 mM KPIPES (pH6.5), 5 mM EGTA, 1 mM
MgCl2, 3.7% formalin, 0.25% gluteraldehyde, and 0.2% Triton. Embryos were blocked in 10% Nor-
mal Goat Serum (Vector Labs) in PBSTw for 30 min and then incubated with monoclonal anti-a-tubu-
lin (1:500) (clone DM1A) diluted in blocking reagent overnight at 4C. Following four washes in
PBSTw, the embryos were incubated in Alexa 568 goat anti mouse IgG (Invitrogen) (1:500) diluted in
blocking reagent for 2 hr at RT and then rinsed four times for 20 min each in PBSTw prior to mount-
ing in agarose and confocal imaging.
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Immunofluorescence for E-Cadherin
Embryos were fixed with 4% PFA in PEMTT (0.1 M PIPES, 5 mM EGTA, 2 mM MgCl2  6H2O, 0.1%
TritonX-100, 0.1% Tween 20, pH 6.8) overnight. Embryos were then washed with 1  PEMTT buffer
and manually dechorionated. Embryos were incubated for one hr with blocking solution (1% DMSO,
10% Normal Goat Serum, 200 mM KCl in PEMTT) at RT. The embryos were incubated with mouse
anti-E-Cadherin antibody (BD) in blocking solution overnight at 4C, which was followed by washing
with 1  PEMTT and incubation with Alexa 568 goat anti mouse IgG (Invitrogen) (1:500) diluted in
blocking solution for 2 hr. The embryos were finally washed with PEMTT and then mounted for
imaging.
Imaging analysis
Fish were anesthetized using Tricaine (United States Biochemical) prior to imaging. Brightfield
images were taken using a Nikon SMZ1500 fluorescence microscope with an Insight Firewire two
digital camera and SPOT advanced software. Fluorescent images were taken using a Zeiss Axio
Observer.Z1 microscope and captured using a Zeiss AxioCam CCD camera. For confocal analysis,
fixed and stained embryos were mounted in 1% low melt agarose (National Diagnostics) dissolved in
water. For cell imaging, 10,000 HEK 293 T cells were plated onto four well MilliCell EZ slides (EMD
Millipore) and transfected as described below. Cells were fixed in 4% paraformaldehyde for 5 min,
washed three times in PBS, permeabilized with 50 ug/mL digitonin in PBS for 5 min at 37C, then
quenched with 50 mM NH4Cl at 37C for 5 min. After 3 washes for 5 min each in PBS, cells were
blocked in 5% goat serum at 37C for 30 min and washed for 3 times for 5 min each in PBS. DAPI
was added at 1:2000 dilution by volume for 2 min, then washed for 5 times for 5 min each in PBS.
Slides were mounted in ProLong Gold Antifade reagent (ThermoFisher Scientific, Waltham, MA)
overnight at 4C. Confocal images were taken using an Olympus Fluoview Microscope with a 60x
lens and analyzed using Fluoview software. Images were processed with ImageJ (1.42q) Imaris (Bit-
plane Inc.) and Adobe PhotoshopCS4 software.
Reporter plasmids and deletion constructs
A genomic region including 1680 bp of sequence upstream of the first exon of cers2b was cloned
into the TOPO TA vector and transferred to the Kpn1/Xho1 sites of the pGL3 basic firefly luciferase
reporter plasmid (Promega). To generate shorter promoter constructs the same 3’ primer was used
along with 5’ primers targeting progressively proximal sequences. These PCR fragments were cloned
into TOPO TA and transferred to the Kpn1/Xho1 sites of the pGL3 basic firefly luciferase reporter
plasmid. A construct containing the first 400 bp of sequence (the most distal 5’ sequences of the
full-length promoter construct) was also generated by PCR and cloned into a pGL3 promoter firefly
luciferase reporter plasmid containing an SV40 promoter (Promega). Primer sequences are:
1680 bp: 5’-ATGAAAATATATGTGAATAAACTGCAA
1631 bp: 5’-AAACGAAGGTTGAGGGAACG
1621 bp: 5’-TGAGGGAACGTTTCTTCATG
1611 bp: 5’-TTTCTTCATGGTTTAAAAGCGTTC
1597 bp: 5’-AAAAGCGTTCTTTAGATTATTAAAATG
1498 bp: 5’-AAAACTGAATATTGAGTAGGGGG
1281 bp: 5’-AAACTCAGTCTCCCGCAAAGTT
881 bp: 5’-TAGGCTATGATGTTGGGTTACTTTGT
common reverse primer: 5’-GTAACTCACGTAGGATCGGC
Two point mutations in the HOX domain (R121W, R122S) were generated using the full-length
1680 bp pGL3 construct via site directed mutagenesis. Likewise, two point mutations in the Lag
domain (H212D, H213D) were similarly generated. Mutations were confirmed by directly sequencing
the plasmids.
In vitro transcription
RNA used for micro-injection was obtained by in vitro transcription using the linearized vector pRL-
SV40 (Promega). Following linearization of the template with BamH1, one microgram was used to
generate capped mRNAs with the mMessage mMachine kit (Ambion), followed by precipitation with
LiCl. RNA was quantified by optical density, and integrity was confirmed by gel electrophoresis.
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Microinjection and luciferase assays
Single cell staged embryos were injected with 20 pg of luciferase reporter DNA and 0.05 pg of RNA
encoding Renilla luciferase (to control for injection, lysate harvest, etc.). Following microinjection,
embryos were cultured in 1x E3 solution until 50% epiboly, at which point three embryos were col-
lected and lysed in 50 ml of 1x Passive Lysis Buffer (Promega). Luciferase assays were performed
according to the manufacturer’s instructions. For each assay, 20 ml of lysate was added to 100 ml of
luciferase substrate [LARII], and luminosity was measured in a Turner TD-20e luminometer. The signal
was quenched using 100 ml of stop and glo buffer and renilla luciferase activity was measured. The
firefly luciferase values were divided by corresponding values of the control renilla luciferase.
Transfection assays
Human (embryonic kidney) 293T/17 cells were purchased from ATCC (CRL-11268), with validated
certificate of analysis provided by ATCC. Cell cultures were routinely tested and found negative for
mycoplasma. 250,000 293 T cells per well in 24 well dishes were transfected with Lipofectamine LTX
Reagent with Plus Reagent (ThermoFisher, Waltham, MA) with 250 ng of a PCS2 +expression vector,
with or without the cers2b cDNA, along with 250 ng of pGL3 reporter plasmid as described above
and 5 ng of CMV-RL to normalize for transfection efficiency and lysate harvest, for 24 hr. Cells were
then washed with PBS and incubated with or without 10 mM sphingosine for 6 hr. Cells were subse-
quently lysed in 100 ml of 1x Passive Lysis Buffer per well (Promega). Luciferase assays were per-
formed as described above.
Cell lysates and western blotting
293 T cells were cultured in 10 cm dishes to 70% confluence and transfected with 6 mg of Cers2
human ORF expression plasmid (OriGene) using Lipofectamine LTX Reagent with Plus Reagent
(ThermoFisher, Waltham, MA) for 24 hr. Cells were then washed with PBS and incubated with or
without 10 mM sphingosine for 6 hr. Subsequently the NE-PER Nuclear Cytoplasmic Extraction
Reagent kit (ThermoFisher, Waltham, MA) was used to generate nuclear and cytoplasmic fractions.
Nuclear membrane sub-fractionation was accomplished using the Minute Nuclear Envelope Protein
Extraction Kit (inVent). For western blotting, cellular samples were lysed in buffer (20 mM Tris pH
7.5,150 mM NaCl, 1% NP-40, with cOmplete Mini Protease Inhibitor Cocktail (Sigma) added immedi-
ately prior to use) and heated in 4x NuPage LDS Sample buffer and 10x NuPage Reducing Agent
(both ThermoFisher, Waltham, MA) for 10 min at 95C. Proteins were resolved by electrophoresis on
pre-cast 10% NuPage Bis-Trisgels and transferred to PVDF membranes using the iBlot system (both
from Invitrogen). Membranes were blocked in 3% BSA in TBS with 1% Tween-20. Membranes were
probed overnight with anti-Cers2 antibody (Sigma) at a 1:250 dilution, or with anti-GAPDH antibody
(Abcam 9484) at 1:10,000 as a control for cytoplasmic proteins, anti-TATA Binding Protein (Abcam
51841) at 1:1000 as a control for nuclear proteins, and anti-LaminB1 (Abcam 16048) at 1:5000 as a
control for nuclear envelope proteins. Blots were then probed with HRP-tagged secondary antibod-
ies (Bio-Rad) and West Pico Chemiluminescence Reagent (Pierce) at 1:2000 in 5% milk-TBST for 1 hr
at RT. Images were obtained and analyzed by c-DiGit Blot Scanner (LI-COR) and the corresponding
Image Studio software.
In situ hybridization
Whole mount in situ hybridization was performed as described (Alexander et al., 1998). Ovaries
were removed from mutant or wildtype female adult fish, and oocytes gently dissociated in PBS. Fol-
lowing fixation in 4% paraformaldehyde (Sigma), hybridization was performed at 70C in 50% form-
amide buffer (Roche) with a digoxigenin-labeled RNA probe for cers2b, synthesized in vitro as an
anti-sense strand using T7 polymerase from the BamH1-linearized cDNA clone.
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